Extension Study of Protocol DFA102 to Examine the Long-Term Safety, Tolerability, and Effect on Body Weight of Pramlintide Administered in Combination With Metreleptin
The recruitment status of this study is unknown because the information has not been verified recently.
Verified January 2009 by Amylin Pharmaceuticals, LLC..
Recruitment status was Active, not recruiting
Recruitment status was Active, not recruiting
Sponsor:
Amylin Pharmaceuticals, LLC.
Information provided by:
Amylin Pharmaceuticals, LLC.
ClinicalTrials.gov Identifier:
NCT00819234
First received: December 24, 2008
Last updated: January 7, 2009
Last verified: January 2009
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study is ongoing, but not recruiting participants. |
|---|---|
| Estimated Study Completion Date: | November 2009 |
| Estimated Primary Completion Date: | November 2009 (Final data collection date for primary outcome measure) |